Showing results (1301-1310 of 1,614) with videos related to

Sort By:
Pageof 162
RSC Medicinal Chemistry|September 8, 2025
Bio-reductive Co(iii)-doxorubicin complex for cancer cell-selective delivery of doxorubicin and potent anticancer activitySharmila Wahengbam, Himanshi Sharma, Phamdom Romabai Chanu, et al.
RSC Medicinal Chemistry|September 8, 2025
Discovery of novel dehydroabietylamine-pyrimidine hybrids: design, synthesis and anti-tumor evaluationZhen-Wei Zhang, Ruo-Chen Huang, Kai Xiong, et al.
RSC Medicinal Chemistry|October 22, 2025
Investigation of the multifunctional profile of dihydroquinazoline derivatives as potential therapeutics for Alzheimer's diseaseKailash Jangid, Bharti Devi, Ruby Dahiya, et al.
RSC Medicinal Chemistry|October 22, 2025
The versatile synthesis and biological evaluation of all-alkyl biscationic quaternary phosphonium compounds: atom-economical and potent disinfectantsDiana McDonough, Elise L Bezold, William M Wuest, et al.
RSC Medicinal Chemistry|October 13, 2025
Discovery of a first-in-class SLIT2 binder disrupting the SLIT2/ROBO1 axis via DNA-encoded library (DEL) screeningShaoren Yuan, Somaya A Abdel-Rahman, Nelson García Vázquez, et al.
RSC Medicinal Chemistry|August 4, 2025
A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2Laura Hillebrand, Guiqun Wang, Alexander Rasch, et al.
RSC Medicinal Chemistry|August 6, 2025
Design, synthesis, and anti-plasmodial profiling of oxalamide-linked 4-aminoquinoline-phthalimide hybridsNikita Gupta, Kewal Kumar, Raghu Raj, et al.
RSC Medicinal Chemistry|August 6, 2025
Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabineXin Huang, Hang Wu, Ke Zhu, et al.
RSC Medicinal Chemistry|July 30, 2025
Design, synthesis and biological evaluation of N-pyridinyl ureidobenzenesulfonates and their hydrochloride salts as novel water-soluble dihydroorotate dehydrogenase inhibitors inducing differentiation of acute myeloid leukemia cellsVincent Ouellette, Chahrazed Bouzriba, Atziri Corin Chavez Alvarez, et al.
RSC Medicinal Chemistry|July 31, 2025
Computer-aided discovery of triazolothiadiazoles as DYRK1A-targeted neuroprotective agentsXinxin Si, Yaling Wang, Nianzhuang Qiu, et al.
Pageof 162